Skip to main content
MedPathMedPath Home
Clinical Trials/NCT00098189
NCT00098189
Completed
Not Applicable

A Follow-Up Study of Patients Previously Treated in a Core Study With Pimecrolimus Tablets for Chronic Plaque-Type Psoriasis

Novartis0 sitesJuly 2004
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPsoriasis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Psoriasis
Sponsor
Novartis
Status
Completed
Last Updated
19 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

This extension study is being conducted to collect post-treatment safety information on patients who previously participated in the core clinical trial.

Registry
clinicaltrials.gov
Start Date
July 2004
End Date
TBD
Last Updated
19 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Novartis

Eligibility Criteria

Inclusion Criteria

  • •Consenting patients who participated in the core clinical trial

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic DermatitisAtopic Dermatitis
NCT00098150Novartis66
Recruiting
Not Applicable
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy ProductHematological MalignancySolid Tumor Malignancy
NCT05768269Century Therapeutics, Inc.375
Completed
Not Applicable
Long-term Safety Follow-up Study of Patients Having Received HepaStem (SAF001)Urea Cycle DisordersCrigler Najjar Syndrome
NCT02051049Cellaion SA9
Completed
Phase 1
Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM® Phase-I/IIa Clinical Trial.Alzheimer's Disease
NCT03172117Medipost Co Ltd.36
Unknown
Not Applicable
Safety and Efficacy Study of Spinal TetheringAdolescent Idiopathic Scoliosis
NCT02897453Zimmer Biomet56